Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC
ABSTRACT Aims Hepatocellular carcinoma (HCC) is a type of malignant tumor and the sixth leading cause of death worldwide. It is caused by HBV, HCV infection, and alcohol consumption. MicroRNAs are typically small, non‐coding RNAs that are involved in the regulation of mRNA expression. Recent studies...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Cancer Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.70049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850058134330015744 |
|---|---|
| author | Yasmeen Ishaq Bisma Rauff Badr Alzahrani Aqsa Ikram Hasnain Javed Imran Abdullah Ghulam Mujtaba |
| author_facet | Yasmeen Ishaq Bisma Rauff Badr Alzahrani Aqsa Ikram Hasnain Javed Imran Abdullah Ghulam Mujtaba |
| author_sort | Yasmeen Ishaq |
| collection | DOAJ |
| description | ABSTRACT Aims Hepatocellular carcinoma (HCC) is a type of malignant tumor and the sixth leading cause of death worldwide. It is caused by HBV, HCV infection, and alcohol consumption. MicroRNAs are typically small, non‐coding RNAs that are involved in the regulation of mRNA expression. Recent studies revealed miRNAs' regulatory roles in liver cancer, linked to risk factors like HCV, HBV infection, alcoholism, drug use, and auto‐immune hepatic disorders. Circular RNAs also belong to the class of non‐coding RNAs; they act as ceRNAs to regulate miRNA expression and regulate different oncogenic pathways in HCC progression. This study aimed to check the hsa_circ_0070269, circ‐102,166 (hsa_circ_0004913), and miR‐182 expression in HCV induced HCC patients. Methods Data analysis was used to find out studies related to the role of hsa_circ_0070269, circ‐102,166, and miR‐182 in HCC; miR‐182 targeted genes, their role in different diseases; and miR‐182 interactions with hsa_circ_0070269 and circ‐102,166 in the HCC. It was revealed that the hsa_circ_0070269, circ‐102,166, and miR‐182 correlations in HCV induced HCC have not been explored yet. Therefore, to validate data from literature mining, expression analysis of dysregulated hsa_circ_0070269, circ‐102,166, and miR‐182 was performed in HCV induced HCC patients using RT‐PCR. Results It was found that miR‐182 was significantly upregulated and acts as an oncomiRNA in HCV induced HCC, and hsa_circ_0070269 and circ‐102,166 were downregulated in HCV induced HCC. We have identified that miR‐182 relative expression level was significantly high (p < 0.0029), while has_circ_0070269 (p < 0.002) and circ‐102,166 (p < 0.002) were significantly downregulated in HCV‐HCC patients as compared to expression in healthy individuals. Conclusion Our data revealed that miR‐182 acts as an oncomiRNA in HCC development. Hsa_circ_0070269 and circ‐102,166 are highly expressed in healthy controls compared to HCV induced HCC patients, can sponge miR‐182 expression by acting as tumor suppressors, and can be used as biomarkers and targets for HCC treatment. |
| format | Article |
| id | doaj-art-f10c2014e92a4c61ba4dbe2a7d657bd7 |
| institution | DOAJ |
| issn | 2573-8348 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Reports |
| spelling | doaj-art-f10c2014e92a4c61ba4dbe2a7d657bd72025-08-20T02:51:14ZengWileyCancer Reports2573-83482024-12-01712n/an/a10.1002/cnr2.70049Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCCYasmeen Ishaq0Bisma Rauff1Badr Alzahrani2Aqsa Ikram3Hasnain Javed4Imran Abdullah5Ghulam Mujtaba6Institute of Molecular Biology and Biotechnology (IMBB) University of Lahore (UOL) Lahore PakistanDepartment of Biomedical Engineering UET Lahore Narowal PakistanDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences Jouf University Sakaka Saudi ArabiaInstitute of Molecular Biology and Biotechnology (IMBB) University of Lahore (UOL) Lahore PakistanProvincial Public Health reference lab Lahore Punjab AIDS Control Program Lahore PakistanInstitute of Nuclear Medicine & Oncology (INMOL) Cancer Hospital Lahore PakistanInstitute of Nuclear Medicine & Oncology (INMOL) Cancer Hospital Lahore PakistanABSTRACT Aims Hepatocellular carcinoma (HCC) is a type of malignant tumor and the sixth leading cause of death worldwide. It is caused by HBV, HCV infection, and alcohol consumption. MicroRNAs are typically small, non‐coding RNAs that are involved in the regulation of mRNA expression. Recent studies revealed miRNAs' regulatory roles in liver cancer, linked to risk factors like HCV, HBV infection, alcoholism, drug use, and auto‐immune hepatic disorders. Circular RNAs also belong to the class of non‐coding RNAs; they act as ceRNAs to regulate miRNA expression and regulate different oncogenic pathways in HCC progression. This study aimed to check the hsa_circ_0070269, circ‐102,166 (hsa_circ_0004913), and miR‐182 expression in HCV induced HCC patients. Methods Data analysis was used to find out studies related to the role of hsa_circ_0070269, circ‐102,166, and miR‐182 in HCC; miR‐182 targeted genes, their role in different diseases; and miR‐182 interactions with hsa_circ_0070269 and circ‐102,166 in the HCC. It was revealed that the hsa_circ_0070269, circ‐102,166, and miR‐182 correlations in HCV induced HCC have not been explored yet. Therefore, to validate data from literature mining, expression analysis of dysregulated hsa_circ_0070269, circ‐102,166, and miR‐182 was performed in HCV induced HCC patients using RT‐PCR. Results It was found that miR‐182 was significantly upregulated and acts as an oncomiRNA in HCV induced HCC, and hsa_circ_0070269 and circ‐102,166 were downregulated in HCV induced HCC. We have identified that miR‐182 relative expression level was significantly high (p < 0.0029), while has_circ_0070269 (p < 0.002) and circ‐102,166 (p < 0.002) were significantly downregulated in HCV‐HCC patients as compared to expression in healthy individuals. Conclusion Our data revealed that miR‐182 acts as an oncomiRNA in HCC development. Hsa_circ_0070269 and circ‐102,166 are highly expressed in healthy controls compared to HCV induced HCC patients, can sponge miR‐182 expression by acting as tumor suppressors, and can be used as biomarkers and targets for HCC treatment.https://doi.org/10.1002/cnr2.70049ceRNAcircRNAHCV induced HCChepatocellular carcinomamiRNAoncogenic pathways |
| spellingShingle | Yasmeen Ishaq Bisma Rauff Badr Alzahrani Aqsa Ikram Hasnain Javed Imran Abdullah Ghulam Mujtaba Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC Cancer Reports ceRNA circRNA HCV induced HCC hepatocellular carcinoma miRNA oncogenic pathways |
| title | Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC |
| title_full | Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC |
| title_fullStr | Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC |
| title_full_unstemmed | Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC |
| title_short | Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC |
| title_sort | bioinformatics and experimental insights into mir 182 hsa circ 0070269 and circ 102 166 as therapeutic targets for hcv associated hcc |
| topic | ceRNA circRNA HCV induced HCC hepatocellular carcinoma miRNA oncogenic pathways |
| url | https://doi.org/10.1002/cnr2.70049 |
| work_keys_str_mv | AT yasmeenishaq bioinformaticsandexperimentalinsightsintomir182hsacirc0070269andcirc102166astherapeutictargetsforhcvassociatedhcc AT bismarauff bioinformaticsandexperimentalinsightsintomir182hsacirc0070269andcirc102166astherapeutictargetsforhcvassociatedhcc AT badralzahrani bioinformaticsandexperimentalinsightsintomir182hsacirc0070269andcirc102166astherapeutictargetsforhcvassociatedhcc AT aqsaikram bioinformaticsandexperimentalinsightsintomir182hsacirc0070269andcirc102166astherapeutictargetsforhcvassociatedhcc AT hasnainjaved bioinformaticsandexperimentalinsightsintomir182hsacirc0070269andcirc102166astherapeutictargetsforhcvassociatedhcc AT imranabdullah bioinformaticsandexperimentalinsightsintomir182hsacirc0070269andcirc102166astherapeutictargetsforhcvassociatedhcc AT ghulammujtaba bioinformaticsandexperimentalinsightsintomir182hsacirc0070269andcirc102166astherapeutictargetsforhcvassociatedhcc |